Cancer Letters
Volume 229, Issue 1 , Page 149, 8 November 2005

Erratum to ‘In vivo reversal of doxorubicin resistance by (−)-epigallocatechin gallate in a solid human carcinoma xenograft’ [Cancer Letters 208 (2004) 179–186]☆

  • Qiang Zhang
    • ,
  • Dongzhi Wei

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +86 21 64252981; fax: +86 21 64250068.
    • ,
  • Jianwen Liu

      Affiliations

    • Dr Liu is also a corresponding author for this paper.

State Key Laboratory of Bioreactor Engineering, New World Institute of Biotechnology, East China University of Science and Technology, Shanghai 200237, People's Republic of China

Article Outline

 

The Publisher regrets that in the original printing of the above-mentioned article, Dr Liu was not indicated as a second corresponding author. This has now been corrected as appropriate.

PII: S0304-3835(04)00775-X

doi:10.1016/j.canlet.2004.10.001

Refers to article:

  • In vivo reversal of doxorubicin resistance by (−)-epigallocatechin gallate in a solid human carcinoma xenograft

    Qiang Zhang, Dongzhi Wei, Jianwen Liu
    Cancer Letters 28 May 2004 (Vol. 208, Issue 2, Pages 179-186)

Cancer Letters
Volume 229, Issue 1 , Page 149, 8 November 2005

Article Tools